RATIONALE: Schizophrenia and stimulant-induced psychosis (SIP) represent two different forms of psychotic disorder, with different etiologies. While many of the symptoms of psychosis are common to both disorders, there have been few direct comparisons between these conditions, especially when controlling for stimulant use in individuals with schizophrenia. OBJECTIVES: We directly compared both psychotic disorders with a comprehensive battery of clinical, neurocognitive and neuroanatomical measures. This included one group with SIP (and concurrent stimulant dependence) and two groups with schizophrenia (either with or without concurrent stimulant dependence). METHODS: Ninety-six participants were recruited from a marginalized urban population, which included 39 with SIP (and concurrent stimulant dependence), 18 with schizophrenia (without stimulant dependence), and 39 with schizophrenia (with concurrent stimulant dependence). All subjects had extensive clinical and neurocognitive evaluations, complemented with structural MRI including diffusion tensor imaging (DTI) sequences to determine regional brain volumes and white matter connectivity. RESULTS: Both positive and negative symptoms were greater in the SZ-dependent group than the other two. Neurocognitive function was broadly similar. The structural brain imaging revealed lateralized changes to the left parietal/temporal lobe, in which regional volumes were smaller in the SZ-dependent than the SZ-non-dependent group. DTI analysis indicated extensive decreases in fractional anisotropy, with parallel increases in radial diffusivity, in the SIP group compared to the SZ-dependent group. CONCLUSIONS: These findings reveal both similarities and differences between SIP and schizophrenia. Furthermore, schizophrenia with concurrent stimulant dependence may be associated with a different clinical and neuroanatomical profile as compared to schizophrenia alone.
RATIONALE: Schizophrenia and stimulant-induced psychosis (SIP) represent two different forms of psychotic disorder, with different etiologies. While many of the symptoms of psychosis are common to both disorders, there have been few direct comparisons between these conditions, especially when controlling for stimulant use in individuals with schizophrenia. OBJECTIVES: We directly compared both psychotic disorders with a comprehensive battery of clinical, neurocognitive and neuroanatomical measures. This included one group with SIP (and concurrent stimulant dependence) and two groups with schizophrenia (either with or without concurrent stimulant dependence). METHODS: Ninety-six participants were recruited from a marginalized urban population, which included 39 with SIP (and concurrent stimulant dependence), 18 with schizophrenia (without stimulant dependence), and 39 with schizophrenia (with concurrent stimulant dependence). All subjects had extensive clinical and neurocognitive evaluations, complemented with structural MRI including diffusion tensor imaging (DTI) sequences to determine regional brain volumes and white matter connectivity. RESULTS: Both positive and negative symptoms were greater in the SZ-dependent group than the other two. Neurocognitive function was broadly similar. The structural brain imaging revealed lateralized changes to the left parietal/temporal lobe, in which regional volumes were smaller in the SZ-dependent than the SZ-non-dependent group. DTI analysis indicated extensive decreases in fractional anisotropy, with parallel increases in radial diffusivity, in the SIP group compared to the SZ-dependent group. CONCLUSIONS: These findings reveal both similarities and differences between SIP and schizophrenia. Furthermore, schizophrenia with concurrent stimulant dependence may be associated with a different clinical and neuroanatomical profile as compared to schizophrenia alone.
Authors: Alasdair M Barr; William J Panenka; G William MacEwan; Allen E Thornton; Donna J Lang; William G Honer; Tania Lecomte Journal: J Psychiatry Neurosci Date: 2006-09 Impact factor: 6.186
Authors: Kegang Hua; Jiangyang Zhang; Setsu Wakana; Hangyi Jiang; Xin Li; Daniel S Reich; Peter A Calabresi; James J Pekar; Peter C M van Zijl; Susumu Mori Journal: Neuroimage Date: 2007-08-15 Impact factor: 6.556
Authors: Susumu Mori; Kenichi Oishi; Hangyi Jiang; Li Jiang; Xin Li; Kazi Akhter; Kegang Hua; Andreia V Faria; Asif Mahmood; Roger Woods; Arthur W Toga; G Bruce Pike; Pedro Rosa Neto; Alan Evans; Jiangyang Zhang; Hao Huang; Michael I Miller; Peter van Zijl; John Mazziotta Journal: Neuroimage Date: 2008-01-03 Impact factor: 6.556
Authors: Kristina M Gicas; Allen E Thornton; Kristina Waclawik; Nena Wang; Andrea A Jones; William J Panenka; Donna J Lang; Geoff N Smith; Fidel Vila-Rodriguez; Olga Leonova; Alasdair M Barr; Ric M Procyshyn; Tari Buchanan; Wayne Su; Alexandra T Vertinsky; Alexander Rauscher; G William MacEwan; William G Honer Journal: Arch Clin Neuropsychol Date: 2019-06-01 Impact factor: 2.813
Authors: Taylor S Willi; Donna J Lang; William G Honer; Geoff N Smith; Allen E Thornton; William J Panenka; Ric M Procyshyn; Fidel Vila-Rodriguez; Wayne Su; A Talia Vertinsky; Olga Leonova; Alexander Rauscher; G William MacEwan; Alasdair M Barr Journal: Schizophr Res Date: 2016-08-04 Impact factor: 4.939
Authors: J Mazziotta; A Toga; A Evans; P Fox; J Lancaster; K Zilles; R Woods; T Paus; G Simpson; B Pike; C Holmes; L Collins; P Thompson; D MacDonald; M Iacoboni; T Schormann; K Amunts; N Palomero-Gallagher; S Geyer; L Parsons; K Narr; N Kabani; G Le Goualher; J Feidler; K Smith; D Boomsma; H Hulshoff Pol; T Cannon; R Kawashima; B Mazoyer Journal: J Am Med Inform Assoc Date: 2001 Sep-Oct Impact factor: 4.497
Authors: Fidel Vila-Rodriguez; William J Panenka; Donna J Lang; Allen E Thornton; Talia Vertinsky; Hubert Wong; Alasdair M Barr; Ric M Procyshyn; J J Sidhu; Geoffrey N Smith; T Buchanan; Mel Krajden; Michael Krausz; Julio S Montaner; G William MacEwan; William G Honer Journal: Am J Psychiatry Date: 2013-12 Impact factor: 18.112
Authors: Jade C Yau; Shu Min Yu; William J Panenka; Hadley Pearce; Kristina M Gicas; Ric M Procyshyn; Caroline MacCallum; William G Honer; Alasdair M Barr Journal: BMC Psychiatry Date: 2019-11-01 Impact factor: 3.630